---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-257692"
form_type: "8-K"
ticker: "DNA"
cik: "0001830214"
company_name: "Ginkgo Bioworks Holdings, Inc."
filed_at: "2022-10-04T23:59:59+00:00"
generated_at: "2026-06-23T05:40:35.916622+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Ginkgo recasts 2021 financials into Foundry and Biosecurity segments

## Summary
- Historical segment data revised to two segments: Foundry and Biosecurity (previously one segment).
- No changes to previously reported total revenue, net income, or cash flows.
- Segment change was implemented in Q1 2022; this filing provides recast comparative periods.
- Recast information intended for incorporation by reference into future registration statements.

## SEC filing metadata
- accession: 0001193125-22-257692
- form_type: 8-K
- ticker: DNA
- cik: 0001830214
- company_name: Ginkgo Bioworks Holdings, Inc.
- filed_at: 2022-10-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1830214/000119312522257692/0001193125-22-257692-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1830214/000119312522257692/d238484d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-257692
- JSON: https://secwatch.observer/filing/0001193125-22-257692.json
- Plain text: https://secwatch.observer/filing/0001193125-22-257692.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.